Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Menkiszak, Janusz
99  Ergebnisse:
Personensuche X
?
1

Association of recurrent mutations in BRCA1, BRCA2, RAD51C,..:

Ogrodniczak, Alicja ; Menkiszak, Janusz ; Gronwald, Jacek...
Hereditary Cancer in Clinical Practice.  20 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
2

eP160: Bilateral oophorectomy and the risk of breast cancer..:

joanne Kotsopoulos ; Lubinski, Jan ; Gronwald, Jacek...
Genetics in Medicine.  24 (2022)  3 - p. S98 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK..:

Łukomska, Alicja ; Menkiszak, Janusz ; Gronwald, Jacek...
Cancers.  13 (2021)  4 - p. 849 , 2021
Link: https://doi.org/10.3390/..
 
?
4

Analysis of PONV incidence in gynaecology patients:

Ćwiek, Dorota ; Wojciechowska, Arleta ; Szymoniak, Katarzyna...
Pomeranian Journal of Life Sciences.  66 (2020)  1 - p. 11-21 , 2020
Link: https://doi.org/10.21164..
 
?
5

Selected features of breast and peritoneal cancers diagnose..:

Menkiszak, Janusz ; Chudecka-Głaz, Anita ; Cymbaluk-Płoska, Aneta...
Hereditary Cancer in Clinical Practice.  17 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
6

A comparison of ovarian cancer mortality in women with BRCA..:

Gronwald, Jacek ; Lubinski, Jan ; Huzarski, Tomasz...
Gynecologic Oncology.  155 (2019)  2 - p. 270-274 , 2019
Link: https://doi.org/10.1016/..
 
?
7

The role of lipocalin-2 serum levels in the diagnostics of ..:

Cymbaluk-Płoska, Aneta ; Chudecka-Głaz, Anita ; Pius-Sadowska, Ewa...
Cancer Biomarkers.  24 (2019)  3 - p. 315-324 , 2019
Link: https://doi.org/10.3233/..
 
?
8

Circulating Serum Level of Visfatin in Patients with Endome..:

Cymbaluk-Płoska, Aneta ; Chudecka-Głaz, Anita ; Pius-Sadowska, Ewa...
BioMed Research International.  2018 (2018)  - p. 1-9 , 2018
Link: https://doi.org/10.1155/..
 
?
9

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer:

Block, Matthew S. ; Vierkant, Robert A. ; Rambau, Peter F....
Mayo Clinic Proceedings.  93 (2018)  3 - p. 307-320 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Risk model in women with ovarian cancer without mutations:

Cymbaluk-Płoska, Aneta ; Chudecka-Głaz, Anita ; Sompolska-Rzechuła, Agnieszka...
Open Medicine.  13 (2018)  1 - p. 565-574 , 2018
Link: https://doi.org/10.1515/..
 
?
11

Suitability assessment of baseline concentration of MMP3, T..:

Cymbaluk-Płoska, Aneta ; Chudecka-Głaz, Anita ; Pius-Sadowska, Ewa...
Journal of Ovarian Research.  11 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
12

Could HE4 level measurements during first-line chemotherapy..:

Chudecka-Głaz, Anita ; Cymbaluk-Płoska, Aneta ; Wężowska, Małgorzata..
PLOS ONE.  13 (2018)  3 - p. e0194270 , 2018
Link: https://doi.org/10.1371/..
 
?
13

Evaluation of biologically active substances promoting the ..:

Cymbaluk-Płoska, Aneta ; Chudecka-Głaz, Anita ; Jagodzińska, Anna...
OncoTargets and Therapy.  11 (2018)  - p. 1363-1372 , 2018
Link: https://doi.org/10.2147/..
 
?
14

HE4 Serum Levels in Patients with BRCA1 Gene Mutation Under..:

Chudecka-Głaz, Anita ; Cymbaluk-Płoska, Aneta ; Strojna, Aleksandra.
Disease Markers.  2017 (2017)  - p. 1-13 , 2017
Link: https://doi.org/10.1155/..
 
?
15

Implementation of an enhanced recovery after surgery (ERAS)..:

Nikodemski, Tomasz ; Biskup, Agnieszka ; Taszarek, Aleksandra...
Współczesna Onkologia.  3 (2017)  - p. 240-243 , 2017
Link: https://doi.org/10.5114/..
 
1-15